Search research articles
Contact Us
Filters
Showing results (141-150 of 171) with videos related to
Page
of 18
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
April 16, 2024
Unresectable biliary tract cancer: Current and future systemic therapy
Danmei Zhang, Klara Dorman, C Benedikt Westphalen, et al.
Nature Communications
|
August 29, 2019
Molecular cobalt corrole complex for the heterogeneous electrocatalytic reduction of carbon dioxide
Sabrina Gonglach, Shounik Paul, Michael Haas, et al.
Nano Letters
|
July 31, 2025
Purcell-Enhanced Emissions from Diamond Color Centers in Slow Light Photonic Crystal Waveguides
Sophie W Ding, Chang Jin, Kazuhiro Kuruma, et al.
Journal of Cancer Research and Clinical Oncology
|
September 16, 2016
Acinar cell carcinoma of the pancreas: a rare disease with different diagnostic and therapeutic implications than ductal adenocarcinoma
Stephan Kruger, Michael Haas, Philipp Johannes Burger, et al.
Anti-Cancer Drugs
|
July 9, 2020
Predictive and prognostic value of magnesium serum level in FOLFIRI plus cetuximab or bevacizumab treated patients with stage IV colorectal cancer: results from the FIRE-3 (AIO KRK-0306) study
Christoph Schulz, Volker Heinemann, Kathrin Heinrich, et al.
Cancers
|
November 27, 2021
Quantitative Imaging Biomarkers of the Whole Liver Tumor Burden Improve Survival Prediction in Metastatic Pancreatic Cancer
Leonie Gebauer, Jan H Moltz, Alexander Mühlberg, et al.
Journal of Cancer Research and Clinical Oncology
|
June 23, 2022
Serum biomarker panel diagnostics in pancreatic ductal adenocarcinoma: the clinical utility of soluble interleukins, IFN-γ, TNF-α and PD-1/PD-L1 in comparison to established serum tumor markers
Klara Dorman, Miriam Gerckens, Stephan Kruger, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
April 13, 2016
Isolated pulmonary metastases define a favorable subgroup in metastatic pancreatic cancer
Stephan Kruger, Michael Haas, Philipp Johannes Burger, et al.
British Journal of Cancer
|
April 28, 2017
Extended RAS analysis and correlation with overall survival in advanced pancreatic cancer
Michael Haas, Steffen Ormanns, Sibylle Baechmann, et al.
Journal of Cancer Research and Clinical Oncology
|
October 24, 2019
Prolonged time to treatment initiation in advanced pancreatic cancer patients has no major effect on treatment outcome: a retrospective cohort study controlled for lead time bias and waiting time paradox
Stephan Kruger, Karoline Schirle, Michael Haas, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 171) with videos related to
Sort By:
Page
of 18
European Journal of Cancer (Oxford, England : 1990)
|
April 16, 2024
Unresectable biliary tract cancer: Current and future systemic therapy
Danmei Zhang, Klara Dorman, C Benedikt Westphalen, et al.
Nature Communications
|
August 29, 2019
Molecular cobalt corrole complex for the heterogeneous electrocatalytic reduction of carbon dioxide
Sabrina Gonglach, Shounik Paul, Michael Haas, et al.
Nano Letters
|
July 31, 2025
Purcell-Enhanced Emissions from Diamond Color Centers in Slow Light Photonic Crystal Waveguides
Sophie W Ding, Chang Jin, Kazuhiro Kuruma, et al.
Journal of Cancer Research and Clinical Oncology
|
September 16, 2016
Acinar cell carcinoma of the pancreas: a rare disease with different diagnostic and therapeutic implications than ductal adenocarcinoma
Stephan Kruger, Michael Haas, Philipp Johannes Burger, et al.
Anti-Cancer Drugs
|
July 9, 2020
Predictive and prognostic value of magnesium serum level in FOLFIRI plus cetuximab or bevacizumab treated patients with stage IV colorectal cancer: results from the FIRE-3 (AIO KRK-0306) study
Christoph Schulz, Volker Heinemann, Kathrin Heinrich, et al.
Cancers
|
November 27, 2021
Quantitative Imaging Biomarkers of the Whole Liver Tumor Burden Improve Survival Prediction in Metastatic Pancreatic Cancer
Leonie Gebauer, Jan H Moltz, Alexander Mühlberg, et al.
Journal of Cancer Research and Clinical Oncology
|
June 23, 2022
Serum biomarker panel diagnostics in pancreatic ductal adenocarcinoma: the clinical utility of soluble interleukins, IFN-γ, TNF-α and PD-1/PD-L1 in comparison to established serum tumor markers
Klara Dorman, Miriam Gerckens, Stephan Kruger, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
April 13, 2016
Isolated pulmonary metastases define a favorable subgroup in metastatic pancreatic cancer
Stephan Kruger, Michael Haas, Philipp Johannes Burger, et al.
British Journal of Cancer
|
April 28, 2017
Extended RAS analysis and correlation with overall survival in advanced pancreatic cancer
Michael Haas, Steffen Ormanns, Sibylle Baechmann, et al.
Journal of Cancer Research and Clinical Oncology
|
October 24, 2019
Prolonged time to treatment initiation in advanced pancreatic cancer patients has no major effect on treatment outcome: a retrospective cohort study controlled for lead time bias and waiting time paradox
Stephan Kruger, Karoline Schirle, Michael Haas, et al.
Page
of 18